Oscity BioSciences
Biotechnology ResearchAlabama, United States11-50 Employees
Oscity BioSciences is a biotechnology research company focused on advancing cannabinoid-derived medications by leveraging a proprietary extraction process to produce high-purity co-crystals. Operating from an FDA-certified cGMP facility in Foley, Alabama, the firm emphasizes stability, solubility, and consistent bioavailability to support research and development across pain, epilepsy, inflammation, autoimmune and neuromuscular conditions, mood disorders, and neuroprotection. The company holds two U.S. patents covering co-crystal solid forms of THC, with an expanded portfolio across other cannabinoids, positioning it as a pioneer in crystalline solid-form technology within the cannabinoid space. Based in Alabama, Oscity describes itself as a biopharmaceutical manufacturing entity specializing in industrial hemp and related cannabinoid research. A recent development noted is the continued progression of its patented co-crystal IP and associated research capabilities at its Alabama facility.
1-888-653-2347 
support@leadiq.com 
